BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 31993821)

  • 1. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive surgery versus percutaneous radio frequency ablation for the treatment of single small (≤3 cm) hepatocellular carcinoma: a case-control study.
    Vitali GC; Laurent A; Terraz S; Majno P; Buchs NC; Rubbia-Brandt L; Luciani A; Calderaro J; Morel P; Azoulay D; Toso C
    Surg Endosc; 2016 Jun; 30(6):2301-7. PubMed ID: 26534770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma.
    Lee J; Jin YJ; Shin SK; Kwon JH; Kim SG; Suh YJ; Jeong Y; Yu JH; Lee JW; Kwon OS; Nahm SW; Kim YS
    Clin Mol Hepatol; 2022 Apr; 28(2):207-218. PubMed ID: 34814239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yen YH; Li WF; Wang CC; Lu SN; Kee KM; Yong CC; Cheng YF; Wang JH; Hu TH; Hung CH; Chen CH
    Surg Oncol; 2022 Jun; 42():101769. PubMed ID: 35468499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.
    Huang J; Hernandez-Alejandro R; Croome KP; Yan L; Wu H; Chen Z; Prasoon P; Zeng Y
    J Gastrointest Surg; 2011 Feb; 15(2):311-20. PubMed ID: 21052859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of radiofrequency ablation versus minimally invasive liver surgery for small hepatocellular carcinoma: a systematic review and meta-analysis.
    Si MB; Yan PJ; Hao XY; Du ZY; Tian HW; Yang J; Han CW; Yang KH; Guo TK
    Surg Endosc; 2019 Aug; 33(8):2419-2429. PubMed ID: 30989373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of radiofrequency ablation and surgery for hepatocellular carcinoma in patients with cirrhosis: A meta-analysis.
    Zhang T; Hu H; Jia Y; Gao Y; Hao F; Wu J; Yang Z; Ren J; Li Z; Liu A; Wu H
    Medicine (Baltimore); 2022 Dec; 101(52):e32470. PubMed ID: 36595979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal radiofrequency ablation versus laparoscopic hepatic resection for the treatment of primary hepatocellular carcinoma within Milan criteria in severely cirrhotic patients: long-term favorable outcomes over 10 years.
    Yamashita YI; Imai K; Kaida T; Yamao T; Tsukamoto M; Nakagawa S; Okabe H; Chikamoto A; Ishiko T; Yoshizumi T; Ikeda T; Maehara Y; Baba H
    Surg Endosc; 2019 Jan; 33(1):46-51. PubMed ID: 29872945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.
    Spolverato G; Vitale A; Ejaz A; Kim Y; Maithel SK; Cosgrove DP; Pawlik TM
    World J Surg; 2015 Jun; 39(6):1474-84. PubMed ID: 25665675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.
    Harada N; Shirabe K; Maeda T; Kayashima H; Takaki S; Maehara Y
    World J Surg; 2016 Jul; 40(7):1709-19. PubMed ID: 26911609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver.
    Vivarelli M; Guglielmi A; Ruzzenente A; Cucchetti A; Bellusci R; Cordiano C; Cavallari A
    Ann Surg; 2004 Jul; 240(1):102-7. PubMed ID: 15213625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis.
    Allaire M; Rekik S; Layese R; Mumana A; Guyot E; Nkontchou G; Bourcier V; Grando V; Ziol M; Nahon P; Ganne-Carrié N; Sutter O; Audureau E; Seror O; Nault JC
    Dig Liver Dis; 2019 Jan; 51(1):86-94. PubMed ID: 30126822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis.
    Guglielmi A; Ruzzenente A; Valdegamberi A; Pachera S; Campagnaro T; D'Onofrio M; Martone E; Nicoli P; Iacono C
    J Gastrointest Surg; 2008 Jan; 12(1):192-8. PubMed ID: 17999123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
    Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
    Zhuang BW; Li W; Wang W; Li B; Lu MD; Kuang M; Xie XH; Xie XY
    Eur Radiol; 2021 Jul; 31(7):5379-5389. PubMed ID: 33404697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.